Spinosad topical Pregnancy and Breastfeeding Warnings

Brand names: Natroba

Medically reviewed by Drugs.com. Last updated on Jan 13, 2025.

Spinosad topical Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: B

Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Spinosad topical Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: No (active component); Yes (benzyl alcohol)

Comments:
-High amounts of benzyl alcohol are potentially harmful to neonates; it is unlikely that levels this high reach breast milk.
-Lactating women may choose to pump and discard breast milk for 8 hours (5 half-lives of benzyl alcohol) after use to avoid infant ingestion of benzyl alcohol.

This drug is not systemically absorbed after topical use; it should not be present in human milk.

The topical suspension contains benzyl alcohol, which may be systemically absorbed through the skin; the amount excreted into human milk with use of this drug is unknown.

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer